Product review: Biosurance R&D for life sciences R&D firms

drugs

This product has been reviewed by bbrokers and rated from one to five based on the policy's key benefits.

* - Poor
**- Average
*** - Good
**** - Very Good
**** - Excellent

 

Product
Biosurance R&D

Underwriter
CFC Underwriting

Commission paid
Negotiable

Coverage
A blended policy specifically designed for research and development (R&D) companies in the life sciences industry.

Minimum premium
£400

Excess
Minimum of £250

Contact
Andrew Tamworth
Email: atamworth@cfcunderwriting.com
Tel: 020 7220 8500

Key benefits
• Damage to R&D stock at premises throughout the supply chain and while in transit worldwide
• Full range

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Polaris at 30 – Ray Vincent

As insurance industry owned Polaris celebrates its 30th birthday, Insurance Age asks experts for their recollections on the dawn of digital trading and what is coming next.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: